Kamran Moghtaderi

Founder and CEO of Eversept Partners, LP, recognized for his expertise in healthcare investments and his focus on high-growth opportunities in the health sector.

Explore Kamran Moghtaderi's largest investments on Profit.com, including companies like Vera Therapeutics Inc, GlaxoSmithKline PLC ADR, and United Therapeutics Corporation, and their significance in his portfolio.

Kamran Moghtaderi’s portfolio updates are typically published quarterly through SEC 13F filings, which provide detailed information about their holdings, including recent buys and sells. Additionally, real-time updates on insider trades are available through Form 4 filings, offering a more timely view of their trading activity.

Kamran Moghtaderi currently invests in companies such as Vera Therapeutics Inc, GlaxoSmithKline PLC ADR, and United Therapeutics Corporation, focusing on sectors like Healthcare and Other.

The largest holding in Kamran Moghtaderi’s portfolio is Vera Therapeutics Inc, accounting for 8.72% of their total investments.

One of Kamran Moghtaderi’s most profitable investments is Nektar Therapeutics, which has generated a return of 488.40% over the past year.

As of 11 May 2026, Kamran Moghtaderi’s portfolio is valued at approximately $1.78B, based on the latest filings available on Profit.com.

Yes, you can use Profit.com to follow Kamran Moghtaderi’s portfolio and gain insights to build your own investment portfolio.

You can follow Kamran Moghtaderi’s portfolio updates on Profit.com, which provides notifications on the latest portfolio transactions as soon as they’re available.

Stay up-to-date with Kamran Moghtaderi’s latest trades by following their portfolio on Profit.com. Enable notifications to receive real-time alerts on their newest buy and sell transactions.